Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2025-06-18 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
中信证券股份有限公司关于益丰大药房连锁股份有限公司向不特定对象发行可转换公司债券2025年第一次临时受托管理事务报告
Audit Report / Information Classification · 95% confidence The document is a detailed report from the bond trustee (中信证券股份有限公司) regarding the convertible bonds issued by 益丰大药房连锁股份有限公司. It includes comprehensive information about the bond issuance, terms, adjustments to conversion price, bondholder meetings, credit ratings, and trustee activities. The document is titled as a "2025年第一次临时受托管理事务报告" (2025 First Interim Trustee Management Report) and contains substantive financial and bond management data. It is not an announcement of a report publication but the report itself. The content focuses on bond issuance and trustee management activities, which aligns with an Audit Report / Information (AR) category, as it involves regulatory compliance, bond management, and audit-related information rather than a full annual report or earnings release. Therefore, the most appropriate classification is AR (Audit Report / Information). FY 2025
2025-06-18 Chinese
益丰药房关于不向下修正“益丰转债”转股价格的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from the board of directors of Yifeng Pharmacy Chain Co., Ltd. regarding the decision not to downward adjust the conversion price of its convertible bonds ('Yifeng Convertible Bonds'). It details the bond issuance, the conditions triggering the price adjustment clause, and the board's resolution not to adjust the conversion price despite the triggering event. The document is a formal disclosure about bond terms and board decisions related to convertible bond pricing, not a financial report, earnings release, or management discussion. It is a regulatory announcement about capital structure and bond terms, specifically about convertible bond price adjustment decisions. This fits best under Capital/Financing Update (CAP) as it concerns bond issuance details and conversion price adjustments, which are financing activities. The document length is 2335 characters, which is typical for an announcement rather than a full report. Therefore, the classification is CAP with high confidence.
2025-06-16 Chinese
关于控股股东及其一致行动人减持股份计划公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding a planned reduction in shareholding by the controlling shareholder and its concerted parties. It details the shareholders involved, their shareholdings, the planned number of shares to be sold, the method (block trade), the timing, and the reasons for the reduction. It also includes risk disclosures and compliance with relevant securities laws and stock exchange rules. There is no financial data, earnings information, or report content. The document is a formal notification of a shareholding change plan by major shareholders, which fits the definition of a Major Shareholding Notification (MRQ). The document length is 3455 characters, which is consistent with a detailed announcement but not a full report. Therefore, the correct classification is MRQ with high confidence.
2025-06-12 Chinese
益丰药房关于因权益分派调整可转债转股价格的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the adjustment of the conversion price of its convertible bonds due to a dividend distribution and related equity events. It includes details about the suspension and resumption of bond conversion, the formula for adjusting the conversion price, and the effective date of the adjustment. The document does not contain financial statements or comprehensive financial data but is focused on a specific capital structure change related to convertible bonds. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2025-06-11 Chinese
益丰药房2024年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is titled as an "Annual Equity Distribution Implementation Announcement" for the year 2024 by Yifeng Pharmacy Chain Co., Ltd. It details the dividend distribution plan, including the dividend per share, relevant dates for record and payment, tax withholding policies, and shareholder meeting approval date. The document is an announcement of the dividend amount and payment details rather than a full financial report or annual report. It is relatively short (2329 characters) and focuses on dividend distribution specifics. Therefore, it fits the category of a Notice of Dividend Amount (DIV).
2025-06-11 Chinese
益丰药房关于预计触发“益丰转债”转股价格向下修正条件的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding the expected triggering of a downward adjustment condition for the conversion price of its convertible bonds. It details bond issuance information, terms for price adjustment, and the procedural steps the company will take if the condition is triggered. The document is an announcement about a capital market event related to convertible bonds and their conversion price adjustment, not a full financial report or earnings release. It does not contain financial statements or detailed financial analysis but rather informs investors about a potential capital structure change and related risk. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is 2451 characters, which is consistent with an announcement rather than a full report.
2025-06-09 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.